Headlands Technologies LLC Moderna, Inc. Transaction History

Headlands Technologies LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$118.5 - $160.53 $1.23 Million - $1.66 Million	-10,344 Reduced 98.17%	193 $23,000
Q1 2023 May 01, 2023	BUY	$135.66 - $197.02 $1.11 Million - $1.62 Million	8,200 Added 350.88%	10,537 $1.62 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $276,654 - $490,863	2,337 New	2,337 $420,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.